F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comDabur India Ltd is one of India’s oldest and most trusted FMCG companies, with a strong presence in healthcare, personal care, home care, and food products. Known for iconic brands like Dabur Chyawanprash, Honey, Real, Vatika, and Hajmola, Dabur has successfully blended Ayurveda with modern FMCG distribution.
With rising health awareness, premiumization in FMCG, rural demand recovery, and strong export presence, Dabur continues to remain a defensive and stable long-term compounder. In this article, we analyze Dabur India Ltd share price targets from 2026 to 2030 based on current market data, fundamentals, shareholding pattern, and long-term FMCG sector outlook.
| Detail | Value |
|---|---|
| Open | ₹502.00 |
| Previous Close | ₹504.30 |
| Day’s High | ₹509.00 |
| Day’s Low | ₹498.55 |
| VWAP | ₹505.15 |
| 52-Week High | ₹577.00 |
| 52-Week Low | ₹433.30 |
| All-Time High | ₹672.00 |
| All-Time Low | ₹5.17 |
| Market Capitalization | ₹90,156 Cr |
| Volume | 9,50,728 |
| Value (Lacs) | ₹4,832.55 |
| 20D Avg Volume | 19,43,402 |
| 20D Avg Delivery (%) | 54.6% |
| Face Value | ₹1 |
| Book Value Per Share | ₹61.78 |
| Dividend Yield | 1.57% |
| Beta | 0.60 |
| UC Limit | ₹554.70 |
| LC Limit | ₹453.90 |
Dabur India Ltd operates across multiple FMCG segments:
Healthcare (Ayurvedic medicines, immunity boosters)
Personal Care (hair oils, oral care, skin care)
Foods & Beverages (juices, honey, nutrition products)
Home Care
The company has a strong rural and urban distribution network, presence in over 120 countries, and a growing focus on natural, herbal, and health-centric products, which aligns well with evolving consumer preferences.
Strong brand recall and trust built over decades
Leadership in ayurvedic and natural products
Diversified FMCG portfolio reducing dependency on a single category
Strong rural distribution and growing international business
Consistent dividend-paying track record
Rising disposable income and urban consumption
Increasing health and wellness awareness post-pandemic
Premiumization supporting margin expansion
FMCG companies offer stability during economic slowdowns
Low beta indicates lower volatility compared to broader markets
| Investor Category | Holding (%) |
|---|---|
| Promoters | 66.23% |
| Other Domestic Institutions | 11.10% |
| Foreign Institutions | 10.06% |
| Mutual Funds | 7.28% |
| Retail & Others | 5.33% |
High promoter holding and solid institutional participation reflect long-term confidence in Dabur’s business model.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2026 | 560 | 610 |
| 2027 | 630 | 700 |
| 2028 | 720 | 800 |
| 2029 | 820 | 920 |
| 2030 | 950 | 1,050 |
These targets are based on steady revenue growth, margin stability, brand-led pricing power, and long-term FMCG demand.
By 2026, normalization of input costs and steady volume growth may support earnings improvement.
Growth Drivers
Recovery in rural demand
Stable operating margins
Growth in health and immunity products
Investment View
Suitable for conservative investors seeking stability.
In 2027, premiumization and international business growth may drive better profitability.
Growth Drivers
Higher contribution from premium products
Export market expansion
Strong brand-led pricing power
Investment View
Good for long-term core portfolio allocation.
By 2028, valuation re-rating may occur with consistent earnings visibility.
Growth Drivers
Expansion in foods and beverages segment
Continued health & wellness trend
Improved operating leverage
Investment View
Attractive for steady compounding investors.
With India’s consumption story strengthening, Dabur may show sustained growth.
Growth Drivers
Rising per capita consumption
Strong rural and urban distribution
Consistent free cash flow generation
Investment View
Favors long-term investors seeking low volatility.
By 2030, Dabur could further strengthen its position as a leading natural FMCG brand.
Growth Drivers
Long-term FMCG demand
Brand trust and innovation
Dividend-led total returns
Investment View
Ideal for long-term wealth creation with low risk.
Dabur India Ltd is considered a defensive FMCG stock known for stability, consistent returns, and lower downside risk. While it may not deliver sharp rallies like high-growth stocks, it excels in steady compounding and capital preservation.
Strong promoter backing
Stable cash flows and dividends
Leadership in ayurvedic and health products
Low volatility (beta 0.60)
Raw material price fluctuations
Slower rural demand growth
Intense FMCG competition
Regular review of quarterly performance is recommended.
Dabur India Ltd remains a high-quality FMCG company with strong brands, stable margins, and long-term growth visibility. Backed by health, wellness, and consumption trends, the stock offers reliable compounding potential. Based on current assumptions, Dabur India Ltd share price could range between ₹950 and ₹1,050 by 2030.
This stock is best suited for long-term, conservative investors seeking stability and consistent returns.
1. What is the current share price of Dabur India Ltd?
It is around ₹500–₹505 as per the latest provided data.
2. What is the share price target for 2026?
The expected range is ₹560 to ₹610.
3. Is Dabur India Ltd a good long-term investment?
Yes, it is considered a stable FMCG stock suitable for long-term investors.
4. What is the share price target for 2030?
The projected range is ₹950 to ₹1,050.
5. What factors influence Dabur’s share price the most?
Consumer demand, raw material costs, brand strength, margins, and overall FMCG sector growth.
Disclaimer: This article is for educational purposes only and not investment advice. Please consult a certified financial advisor before making any investment decisions.
Register & Login